kabutan

PeptiDream Inc.(4587) Summary

4587
TSE Prime
PeptiDream Inc.
1,542.0
JPY
-10.0
(-0.64%)
Jan 29, 3:30 pm JST
10.08
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
1,546.1
Jan 29, 3:24 pm JST
Summary Chart Historical News Financial Result
PER
PBR
3.79
Yield
ー%
Margin Trading Ratio
8.94
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,531.5 JPY 10.00 USD
Previous Close Jan 28
1,552.0 JPY 10.16 USD
High Jan 29, 9:35 am
1,554.0 JPY 10.17 USD
Low Jan 29, 9:07 am
1,521.5 JPY 9.93 USD
Volume
533,700
Trading Value
0.82B JPY 5.38M USD
VWAP
1541.34 JPY 10.08 USD
Minimum Trading Value
154,200 JPY 1,008 USD
Market Cap
0.20T JPY 1.32B USD
Number of Trades
2,207
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
2,642
1-Year High Feb 14, 2025
14,693
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 106,500 1,497,400 14.06
Jan 16, 2026 118,000 1,430,400 12.12
Jan 9, 2026 114,600 1,491,200 13.01
Dec 26, 2025 115,900 1,498,300 12.93
Dec 19, 2025 147,500 1,510,200 10.24
Company Profile
PeptiDream Inc. is a drug discovery venture company that collaborates with major pharmaceutical companies to develop peptide-based drugs. The company has also acquired a radiopharmaceutical business.
Sector
Pharmaceuticals
PeptiDream Inc. is a biotech venture originating from the University of Tokyo, focusing primarily on drug discovery and development using special peptides through its proprietary drug discovery platform system, PDPS. The company engages in collaborative drug research and development using PDPS, technology licensing, and strategic partnerships to expand its in-house pipeline. Through its subsidiary PDR Pharma, PeptiDream Inc. also operates in the radiopharmaceutical business, conducting research, development, manufacturing, and sales of diagnostic and therapeutic radiopharmaceuticals. The company concentrates on developing diagnostic agents for imaging cancer and abnormal brain accumulations, as well as therapeutic radiopharmaceuticals targeting unmet medical needs, particularly in the field of oncology. As a group, PeptiDream Inc. operates across a wide range of areas including research, development, manufacturing, and sales of pharmaceuticals and related products.